Cargando…

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004–2013

BACKGROUND: The Tigecycline Evaluation and Surveillance Trial (TEST) is a global antimicrobial susceptibility surveillance study which has been ongoing since 2004. This report examines the in vitro activity of tigecycline and comparators against clinically important pathogens collected globally betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoban, Daryl J, Reinert, Ralf Rene, Bouchillon, Samuel K, Dowzicky, Michael J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489028/ https://www.ncbi.nlm.nih.gov/pubmed/25958201 http://dx.doi.org/10.1186/s12941-015-0085-1

Ejemplares similares

Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
por: Giammanco, Anna, et al.
Publicado: (2017)

413 In Vitro Activity of Tigecycline against Commonly-Isolated Pathogens of Skin and Skin Structure Infections in the United States – TEST 2011-2013
por: Hackel, Meredith, et al.
Publicado: (2014)

421 Activity of Tigecycline and Comparators Against Lower Respiratory Tract (LRT) Isolates of Enterobacteriaceae from North America and Europe: 2009-2013
por: Hoban, Daryl, et al.
Publicado: (2014)

The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016
por: Decousser, Jean-Winoc, et al.
Publicado: (2018)

Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010
por: Fernández-Canigia, Liliana, et al.
Publicado: (2012)

Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
por: Stefani, Stefania, et al.
Publicado: (2016)

412 In vitro Activity of Key Antimicrobial Agents Against Bacterial Isolates From Intra-abdominal (IAI) and Skin and Wound (SW) Infections: Europe 2004-2013
por: Hoban, Daryl, et al.
Publicado: (2014)

A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012
por: Cattoir, Vincent, et al.
Publicado: (2014)

Longitudinal Assessment of Antimicrobial Susceptibility among Gram-Negative and Gram-Positive Organisms Collected from Italy as Part of the Tigecycline Evaluation and Surveillance Trial between 2004 and 2011
por: Stefani, Stefania, et al.
Publicado: (2013)

Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial
por: Vega, Silvio, et al.
Publicado: (2017)

Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008)
por: Tomic, Viktorija, et al.
Publicado: (2014)

Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
por: Denys, Gerald A, et al.
Publicado: (2013)

Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial
por: Morfin-Otero, Rayo, et al.
Publicado: (2015)

Temporal trends of the in vitro activity of tigecycline and comparator antibiotics against clinical aerobic bacterial isolates collected in Germany, 2006–2014: results of the Tigecycline Evaluation and Surveillance Trial (TEST)
por: Kresken, Michael, et al.
Publicado: (2016)

Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection
por: Yu, Meiling, et al.
Publicado: (2023)

In Vitro Activity of Tigecycline Against Orientia tsutsugamushi
por: Lee, Sun-Myoung, et al.
Publicado: (2016)

Tigecycline Induced Hyperpigmentation of the Skin
por: Vandecasteele, S. J., et al.
Publicado: (2016)

In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline & other antimicrobial agents
por: Albert, M. John
Publicado: (2013)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Tigecycline Susceptibility Trends Among Pathogens Isolated from Complicated Skin and Soft-Tissue Infections in North and Latin America: 2012–2016
por: Hoban, Daryl, et al.
Publicado: (2017)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

Effects of tigecycline and doxycycline in porcine endotoxemia
por: Von Seth, M, et al.
Publicado: (2011)

Therapy of intracellular Staphylococcus aureus by tigecyclin
por: Kreis, Carolin A, et al.
Publicado: (2013)

Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo
por: Pearce, Camron, et al.
Publicado: (2020)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
por: Baron, Jeffrey, et al.
Publicado: (2018)

In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates
por: KARAMANLIOĞLU, Dilek, et al.
Publicado: (2019)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023)

Tigecycline Absorption Improved by Selected Excipients
por: Ziółkowski, Hubert, et al.
Publicado: (2023)

Characterization of Tigecycline Resistance Among Tigecycline Non-susceptible Klebsiella pneumoniae Isolates From Humans, Food-Producing Animals, and in vitro Selection Assay
por: Moghimi, Mohaddeseh, et al.
Publicado: (2021)

Stability studies with tigecycline in bacterial growth medium and impact of stabilizing agents
por: Amann, Lisa F., et al.
Publicado: (2020)

Intra-abdominal infection after tumor surgery: tigecycline combined with β-lactam antibiotics versus tigecycline alone
por: Cai, Xinfeng, et al.
Publicado: (2023)

Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens
por: Ziółkowski, Hubert, et al.
Publicado: (2020)

Source Tracking and Global Distribution of the Tigecycline Non-Susceptible tet(X)
por: Zhang, Rong-min, et al.
Publicado: (2021)

Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment
por: Wang, Qian, et al.
Publicado: (2018)

In Vitro Activity of Rifampicin Combined with Daptomycin or Tigecycline on Staphylococcus haemolyticus Biofilms
por: Szczuka, Ewa, et al.
Publicado: (2015)

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
por: Li, Anqi, et al.
Publicado: (2023)

Tigecycline as a Second-Line Agent for Legionnaires’ Disease in Severely Ill Patients
por: Slawek, Deepika, et al.
Publicado: (2017)

High-dose tigecycline use in severe infections
por: De Pascale, G, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n2sko4ls08s6918vt9m0km8g6m